| Attribute |
Value |
| 52 Week Change |
-0.30400002 |
| Address1 |
230 Harriet Tubman Way |
| All Time High |
17.4 |
| All Time Low |
7.9 |
| Ask |
13.38 |
| Ask Size |
2 |
| Average Daily Volume10 Day |
440,160 |
| Average Daily Volume3 Month |
358,414 |
| Average Volume |
358,414 |
| Average Volume10Days |
440,160 |
| Bid |
7.49 |
| Bid Size |
2 |
| Book Value |
10.172 |
| City |
Millbrae |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
10.34 |
| Current Ratio |
11.75 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
10.52 |
| Day Low |
10.0448 |
| Debt To Equity |
46.276 |
| Display Name |
Eikon Therapeutics |
| Earnings Timestamp |
1,778,529,600 |
| Earnings Timestamp End |
1,778,529,600 |
| Earnings Timestamp Start |
1,778,529,600 |
| Ebitda |
-310,081,984 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
-0.993 |
| Enterprise Value |
307,856,288 |
| Eps Current Year |
-6.34883 |
| Eps Forward |
-6.18528 |
| Eps Trailing Twelve Months |
-6.32 |
| Esg Populated |
0 |
| Exchange |
NMS |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
10.4522 |
| Fifty Day Average Change |
-0.11219978 |
| Fifty Day Average Change Percent |
-0.010734562 |
| Fifty Two Week Change Percent |
-30.400002 |
| Fifty Two Week High |
17.4 |
| Fifty Two Week High Change |
-7.0599995 |
| Fifty Two Week High Change Percent |
-0.40574712 |
| Fifty Two Week Low |
7.9 |
| Fifty Two Week Low Change |
2.44 |
| Fifty Two Week Low Change Percent |
0.30886075 |
| Fifty Two Week Range |
7.9 - 17.4 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,770,301,800,000 |
| Float Shares |
29,843,377 |
| Forward Eps |
-6.18528 |
| Forward P E |
-1.671711 |
| Full Exchange Name |
NasdaqGS |
| Full Time Employees |
384 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.0 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.17385 |
| Held Percent Institutions |
0.64515996 |
| Implied Shares Outstanding |
54,138,628 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Ipo Expected Date |
2,026-02-05 |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Long Business Summary |
Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004 to address brain metastases and primary brain malignancies; EIK1005, a potent WRN helicase inhibitor and anti-tumor agent for MSI-high tumors; and EIK1006, a clinical candidate and next-generation androgen receptor antagonist with activity against multiple clinically emergent variants of androgen receptor. The company was incorporated in 2019 and is based in Millbrae, California. |
| Long Name |
Eikon Therapeutics, Inc. |
| Market |
us_market |
| Market Cap |
559,793,408 |
| Market State |
REGULAR |
| Max Age |
86,400 |
| Message Board Id |
finmb_638227772 |
| Most Recent Quarter |
1,774,915,200 |
| Net Income To Common |
-342,059,008 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
565,748,662 |
| Number Of Analyst Opinions |
5 |
| Open |
10.41 |
| Operating Cashflow |
-223,796,000 |
| Operating Margins |
0.0 |
| Payout Ratio |
0.0 |
| Phone |
341 777 0566 |
| Previous Close |
10.44 |
| Price Eps Current Year |
-1.6286465 |
| Price Hint |
2 |
| Price To Book |
1.016516 |
| Profit Margins |
0.0 |
| Quick Ratio |
11.366 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.09999943 |
| Regular Market Change Percent |
-0.95784897 |
| Regular Market Day High |
10.52 |
| Regular Market Day Low |
10.0448 |
| Regular Market Day Range |
10.0448 - 10.52 |
| Regular Market Open |
10.41 |
| Regular Market Previous Close |
10.44 |
| Regular Market Price |
10.34 |
| Regular Market Time |
1,784,036,164 |
| Regular Market Volume |
20,337 |
| Sand P52 Week Change |
0.20365608 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
54,138,628 |
| Shares Percent Shares Out |
0.0855 |
| Shares Short |
4,631,532 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
4,065,276 |
| Short Name |
Eikon Therapeutics, Inc. |
| Short Percent Of Float |
0.1137 |
| Short Ratio |
11.42 |
| Source Interval |
15 |
| State |
CA |
| Symbol |
EIKN |
| Target High Price |
32.0 |
| Target Low Price |
5.0 |
| Target Mean Price |
24.8 |
| Target Median Price |
29.0 |
| Total Cash |
512,182,016 |
| Total Cash Per Share |
9.461 |
| Total Debt |
254,831,008 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-6.32 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
11.410833 |
| Two Hundred Day Average Change |
-1.0708332 |
| Two Hundred Day Average Change Percent |
-0.09384356 |
| Type Disp |
Equity |
| Volume |
20,337 |
| Website |
https://eikontx.com |
| Zip |
94,030 |